ESC Premium Access

Prognostication in heart failure

Event: ESC CONGRESS 2016
Topic: Prognosis
Session type: Moderated Posters
Date: 27 August 2016
Time: 12:35 - 13:25

Congress Session

7 presentations in this session

Predicting sudden death and pump failure death in patients with heart failure and reduced ejection fraction: competing risk regression analyses of the PARADIGM-HF trial

Speaker: Doctor L. Shen (Glasgow, GB)

Low serum potassium is associated with worse outcomes: Insights from the PARADIGM-HF trial

Speaker: Doctor U. Mogensen (Copenhagen, DK)

Impact of combined atrial fibrillation and heart failure on mortality: 14-year naturalistic follow-up study

Speaker: Doctor O. Ziff (Birmingham, GB)

Predictors of 30-day mortality in patients with acute heart failure at emergency department admission: derivation and validation of the MEESSI-AHF scale

Speaker: Doctor O. Miro (Barcelona, ES)

The impact of T-lymphocytes on atrial fibrillation and mortality in patients with chronic heart failure

Speaker: Mr P. Sulzgruber (Vienna, AT)

Galectin 3 is markedly elevated in severe heart failure and predicts improvement in LV volumes post cardiac resynchronisation therapy

Speaker: Miss S. Chua (Adelaide, South Australia, AU)

Low appendicular skeletal muscle mass is associated with adverse outcomes in patients with acute decompensated heart failure

Speaker: Mr E. Akiyama (Yokohama, JP)

7 speakers from this session

Doctor Li Shen

University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)
0 follower

Doctor Ulrik Madvig Mogensen

Rigshospitalet - Copenhagen University Hospital, Heart Centre, Department of Cardiology, Copenhagen (Denmark)
0 follower

Doctor Oliver Ziff

University of Birmingham, Birmingham (United Kingdom of Great Britain & Northern Ireland)
1 presentation
0 follower

Doctor Oscar Miro

Hospital Clinic de Barcelona, Barcelona (Spain)
15 presentations
0 follower

Mr Patrick Sulzgruber

Medical University of Vienna, Vienna (Austria)
0 follower

Miss Su Jen Chua

, Adelaide, South Australia (Australia)
0 follower

Mr Eiichi Akiyama

Yokohama City University Medical Center, Yokohama (Japan)
0 follower

This platform is supported by

logo Novo Nordisk